Upper arm injury
Conditions
Interventions
Experimental group:0.5% ropivacaine hydrochloride injection + 0.1 mg/kg esketamine hydrochloride injection 30 ml
Control Group:0.5% ropivacaine hydrochloride injection 30 ml
Sponsors
The Second Department of the First Hospital of Jilin University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1.American Society of Anesthesiologists ASA grade I-II; 8.Heart, lung, liver and kidney functions are normal; 9.Aged 18 to 65 years; 10.A BMI of 18.5 to 27.9.
Exclusion criteria
Exclusion criteria: 1.The patient refused to undergo brachial plexus block anesthesia; 2.Patients with allergies to the active ingredient of ketamine or to all excipients; 3.Patients at serious risk of elevated blood pressure or intracranial pressure; 4.Patients with poorly controlled or untreated hypertension (arterial hypertension, resting systolic/diastolic blood pressure greater than 180/110mmHg); 5.Preeclampsia and eclampsia; 6.Patients with untreated or undertreated hyperthyroidism (hyperthyroidism); 7.Taking opioids for more than 10 days per day; 8.Puncture site infection or tumor; 9.Abnormal coagulation function; 10.Neuropsychiatric abnormalities; 11.History of diabetes; 12.History of allergy to narcotic drugs; 13.Cognitive impairment was observed by preoperative MMSE scale test. 14.Patients participating in other clinical studies.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Duration of analgesia;Time of loss of pain; | — |
Secondary
| Measure | Time frame |
|---|---|
| Duration of anesthesia operation;Length of operation; | — |
Countries
China
Contacts
Public ContactQiu Jinpeng
The Second Department of the First Hospital of Jilin University
Outcome results
None listed